Newsroom

An Open Letter from our Chairman & CEO

An update from our Chairman & CEO Daniel O’Day about clinical trials for our investigational treatment.

Daniel O’Day - April 29, 2020

Four Questions with Pankaj Bhargava: Expanding Gilead’s Immuno-Oncology Portfolio

Stories@Gilead - May 30, 2020

Our Partners: Tarik Daniels Focuses on Suicide Prevention and Mental Health Through Art, Advocacy and Affirming Care

Stories@Gilead - May 28, 2020

Four Questions with Ken Takeshita: Inside the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting with Kite

Stories@Gilead - May 21, 2020

Phone:
1-800-GILEAD-5 (1-800-445-3235) 1-800-GILEAD-5 (1-800-445-3235)